Mitochondrial involvement in temporal lobe epilepsy

Experimental Neurology

Volumn 218, Issue 2, 2009, Pages 326-332

  Kudin, Alexei P ^a   Zsurka, Gábor ^a   Elger, Christian E ^a   Kunz, Wolfram S ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Mitochondria; Mitochondrial diseases; Temporal lobe epilepsy

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; MITOCHONDRIAL DNA;

BRAIN MITOCHONDRION; CALCIUM HOMEOSTASIS; DRUG TARGETING; GENE MUTATION; HUMAN; MITOCHONDRIAL RESPIRATION; NERVE CELL; NERVE CELL EXCITABILITY; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; SCLEROSIS; SEIZURE; SYNAPTIC TRANSMISSION; TEMPORAL LOBE EPILEPSY; THERAPY RESISTANCE;

ADENOSINE TRIPHOSPHATE; ANIMALS; BRAIN; CALCIUM; CELL DEATH; EPILEPSY, TEMPORAL LOBE; HUMANS; MITOCHONDRIA; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION;

EID: 67649766716     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.02.014     Document Type: Review

References (86)

1. + transport in canine brain. Stroke 12 (1981) 726-730
2. Baron M., Kudin A.P., and Kunz W.S. Mitochondrial dysfunction in neurodegenerative disorders. Biochem. Soc. Trans. 35 (2007) 1228-1231
3. Bataillard M., Chatzoglou E., Rumbach L., Sternberg D., Tournade A., Lafort P., Jardel C., Maisonobe T., and Lombes A. Atypical MELAS syndrome associated with a new mitochondrial tRNA glutamine point mutation. Neurology 56 (2001) 405-407
4. Bengzon J., Kokaia Z., Elmer E., Nanobashvili A., Kokaia M., and Lindvall O. Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc. Natl. Acad. Sci. U. S. A. 94 (1977) 10432-10437
5. Bindokas V.P., Lee C.C., Colmers W.F., and Miller R.J. Changes in mitochondrial function resulting from synaptic activity in the rat hippocampal slice. J. Neurosci. 18 (1998) 4570-4587
6. Blümcke I., Zuschratter W., Schewe J.C., Suter B., Lie A.A., Riederer B.M., Meier B., Schramm J., Elger C.E., and Wiestler O.D. Cellular pathology of hilar neurons in Ammon's horn sclerosis. J. Comp. Neurol. 414 (1999) 437-453
7. Brini M., Pinton P., King M.P., Davidson M., Schon E.A., and Rizutto R. A calcium signalling defect in the pathogenesis of a mitochondrial DNA inherited oxidative phosphorylation deficiency. Nat. Med. 5 (1999) 951-954
8. Brown M.D., Zhadanov S., Allen J.C., Hosseini S., Newman N.J., Atamonov V.V., Mikhailovskaya I.E., Sukernik R.I., and Wallace D.C. Novel mtDNA mutations and oxidative phosphorylation dysfunction in Russian LHON families. Hum. Genet. 109 (2001) 33-39
9. Campos Y., Lorenzo G., Martin M.A., Torregrosa A., del Hoyo P., Rubio J.C., Garcia A., and Arenas J. A mitochondrial tRNA(Lys) gene mutation (T8316C) in a patient with mitochondrial myopathy, lactic acidosis, and stroke-like episodes. Neuromuscul. Disord. 10 (2000) 493-496
10. Canafoglia L., Franceschetti S., Antozzi C., Carrara F., Farina L., Granata T., Lamantea E., Savoiardo M., Uziel G., Villani F., Zeviani M., and Avanzini G. Epileptic phenotypes associated with mitochondrial disorders. Neurology 56 (2001) 1340-1346
11. Chaturvedi R.K., and Beal M.F. Mitochondrial approaches for neuroprotection. Ann. N. Y. Acad. Sci. 1147 (2008) 395-412
12. Cock H., and Schapira A.H.V. Mitochondrial DNA mutations and mitochondrial dysfunction in epilepsy. Epilepsia 40 Suppl. 3 (1999) 33-40
13. De Coo I.F., Renier W.O., Ruitenbeek W., Ter Laak H.J., Bakker M., Schägger H., Van Oost B.A., and Smeets H.J. A 4-base pair deletion in the mitochondrial cytochrome b gene associated with parkinsonism/MELAS overlap syndrome. Ann. Neurol. 45 (1999) 130-133
14. De Vries D.D., van Engelen B.G., Gabrels F.J., Ruitenbeek W., and van Oost B.A. A second missense mutation in the mitochondrial ATPase 6 gene in Leigh's syndrome. Ann. Neurol. 34 (1993) 410-412
15. DiMauro S., Kulikova R., Tanji K., Bonilla E., and Hirano M. Mitochondrial genes for generalized epilepsies. Adv. Neurol. 79 (1999) 411-419
16. Ferrante R.J., Andreassen O.A., Jenkins B.G., Dedeoglu A., Kuemmerle S., Kubilus J.K., Kaddurah-Daouk R., Hersch S.M., and Beal M.F. Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. J. Neurosci. 15 (2000) 4389-4397
17. Frantseva M.V., Velazquez J.L., Hwang P.A., and Carlen P.L. Free radical production correlates with cell death in an in vitro model of epilepsy. Eur. J. Neurosci. 12 (2000) 1431-1439
18. Goto Y., Nonaka I., and Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348 (1990) 651-653
19. Goto Y., Nonaka I., and Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim. Biophys. Acta 1097 (1991) 238-240
20. Goto Y., Tsugane K., Tanabe Y., Nonaka I., and Horai S. A new point mutation at nucleotide pair 3291 of the mitochondrial tRNA(Leu(UUR)) gene in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Biochem. Biophys. Res. Commun. 202 (1994) 1624-1630
21. Hanna M.G., Nelson I.P., Morgan-Hughes J.A., and Wood N.W. MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity. J. Neurol. Neurosurg. Psychiatry 65 (1998) 512-517
22. Henry T.R., Babb T.L., Engel Jr. J., Mazziotta J.C., Phelps M.E., and Crandall P.H. Hippocampal neuronal loss and regional hypometabolism in temporal lobe epilepsy. Ann. Neurol. 36 (1994) 925-927
23. Hirano M., Kunz W.S., and DiMauro S. Mitochondrial diseases. In: Engel J., and Pedley T.A. (Eds). Epilepsy - A comprehensive textbook III (2008), Lippincott Williams & Wilkins, Philadelphia 2621-2630
24. Holtzman D., Khait I., Mulkern R., Allred E., Rand T., Jensen F., and Kraft R. In vivo development of brain phosphocreatine in normal and creatine-treated rabbit pups. J. Neurochem. 73 (1999) 2477-2484
25. Jaksch M., Klopstock T., Kurlemann G., Dörner M., Hofmann S., Kleinle S., Hegemann S., Weissert M., Müller-Höcker J., Pongratz D., and Gerbitz K.D. Progressive myoclonus epilepsy and mitochondrial myopathy associated with mutations in the tRNA(Ser(UCN)) gene. Ann. Neurol. 44 (1998) 635-640
26. Jarrett S.G., Milder J.B., Liang L.P., and Patel M. The ketogenic diet increases mitochondrial glutathione levels. J. Neurochem. 106 (2008) 1044-1051
27. Kann O., Schuchmann S., Buchheim K., and Heinemann U. Coupling of neuronal activity and mitochondrial metabolism as revealed by NAD(P)H fluorescence signals in organotypic hippocampal slice cultures of the rat. Neuroscience 119 (2003) 87-100
28. Kann O., Kovacs R., Njunting M., Behrens C.J., Otahal J., Lehmann T.N., Gabriel S., and Heinemann U. Metabolic dysfunction during neuronal activation in the ex vivo hippocampus from chronic epileptic rats and humans. Brain 128 (2005) 2396-2407
29. Klivenyi P., Ferrante R.J., Matthews R.T., Bogdanov M.B., Klein A.M., Andreassen O.A., Mueller G., Wermer M., Kaddurah-Daouk R., and Beal M.F. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med. 5 (1999) 347-350
30. Kovacs R., Schuchmann S., Gabriel S., Kann O., Kardos J., and Heinemann U. Free radical-mediated cell damage after experimental status epilepticus in hippocampal slice cultures. J. Neurophysiol. 88 (2002) 2909-2918
31. Kudin A.P., Kudina T.A., Seyfried J., Vielhaber S., Beck H., Elger C.E., and Kunz W.S. Seizure-dependent modulation of mitochondrial oxidative phosphorylation in rat hippocampus. Eur. J. Neurosci. 15 (2002) 1105-1114
32. Kudin A.P., Bimpong-Buta N.Y., Vielhaber S., Elger C.E., and Kunz W.S. Characterization of superoxide-producing sites in isolated brain mitochondria. J. Biol. Chem. 279 (2004) 4127-4135
33. Kudin A.P., Debska-Vielhaber G., Vielhaber S., Elger C.E., and Kunz W.S. The mechanism of neuroprotection by topiramate in an animal model of epilepsy. Epilepsia 45 (2004) 1478-1487
34. Kudin A.P., Debska-Vielhaber G., and Kunz W.S. Characterization of superoxide production sites in isolated rat brain and skeletal muscle mitochondria. Biomed. Pharmacother. 59 (2005) 163-168
35. Kudin A.P., Malinska D., and Kunz W.S. Sites of generation of reactive oxygen species in homogenates of brain tissue determined with the use of respiratory substrates and inhibitors. Biochim. Biophys. Acta 1777 (2008) 689-695
36. Kunz W.S. The role of mitochondria in epileptogenesis. Curr. Opin. Neurol. 15 (2002) 179-184
37. Kunz W.S., Goussakov I.V., Beck H., and Elger C.E. Altered mitochondrial oxidative phosphorylation in hippokampal slices of kainate-treated rats. Brain Res. 826 (1999) 236-242
38. Kunz W.S., Kudin A.P., Vielhaber S., Blümcke I., Zuschratter W., Schramm J., Beck H., and Elger C.E. Mitochondrial complex I deficiency in the epileptic focus of patients with temporal lobe epilepsy. Ann. Neurol. 48 (2000) 766-773
39. Krajewski S., Krajewska M., Ellerby L.M., Welsh K., Xie Z., Deveraux Q.L., Salvesen G.S., Bredesen D.E., Rosenthal R.E., Fiskum G., and Reed J.C. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 5752-5757
40. Liang L.P., Ho Y.S., and Patel M. Mitochondrial superoxide production in kainate-induced hippocampal damage. Neuroscience 101 (2000) 563-570
41. Mancuso M., Filosto M., Mootha V.K., Rocchi A., Pistolesi S., Murri L., DiMauro S., and Siciliano G. A novel mitochondrial tRNAPhe mutation causes MERRF syndrome. Neurology 62 (2004) 2119-2121
42. Manfredi G., Schon E.A., Moraes C.T., Bonilla E., Berry G.T., Sladky J.T., and DiMauro S. A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene. Neuromuscul. Disord. 5 (1995) 391-398
43. Manfredi G., Schon E.A., Bonilla E., Moraes C.T., Shanske S., and DiMauro S. Identification of a mutation in the mitochondrial tRNA(Cys) gene associated with mitochondrial encephalopathy. Hum. Mutat. 7 (1996) 158-163
44. Margerison J.H., and Corsellis J.A. Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. Brain 89 (1966) 499-530
45. Meldrum B.S. Excitotoxicity and selective neuronal loss in epilepsy. Brain Pathol. 3 (1993) 405-412
46. Moraes C.T., Ciacci F., Bonilla E., Jansen C., Hirano M., Rao N., Lovelace R.E., Rowland L.P., Schon E.A., and DiMauro S. Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA(Leu(UUR)) gene an etiologic hot spot?. J. Clin. Invest. 92 (1993) 2906-2915
47. Morten K.J., Cooper J.M., Brown G.K., Lake B.D., Pike D., and Poulton J. A new point mutation associated with mitochondrial encephalomyopathy. Hum. Mol. Genet. 2 (1993) 2081-2087
48. Naini A.B., Lu J., Kaufmann P., Bernstein R.A., Mancuso M., Bonilla E., Hirano M., and DiMauro S. Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF. Arch. Neurol. 62 (2005) 473-476
49. Naviaux R.K., and Nguyen K.V. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann. Neurol. 55 (2004) 706-712
50. Nishigaki Y., Tadesse S., Bonilla E., Shungu D., Hersh S., Keats B.J., Berlin C.I., Goldberg M.F., Vockley J., DiMauro S., and Hirano M. A novel mitochondrial tRNA(Leu(UUR)) mutation in a patient with features of MERRF and Kearns-Sayre syndrome. Neuromuscul. Disord. 13 (2003) 334-340
51. Nishino I., Komatsu M., Kodama S., Horai S., Nonaka I., and Goto Y. The 3260 mutation in mitochondrial DNA can cause mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS). Muscle Nerve 19 (1996) 1603-1604
52. O'Brien T.J., Newton M.R., Cook M.J., Berlangieri S.U., Kilpatrick C., Morris K., and Berkovic S.F. Hippocampal atrophy is not a major determinant of regional hypometabolism in temporal lobe epilepsy. Epilepsia 38 (1997) 74-80
53. Pulkes T., Liolitsa D., Eunson L.H., Rose M., Nelson I.P., Rahman S., Poulton J., Marchington D.R., Landon D.N., Debono A.G., Morgan-Hughes J.A., and Hanna M.G. New phenotypic diversity associated with the mitochondrial tRNA(SerUCN) gene mutation. Neuromuscul. Disord. 15 (2005) 364-371
54. Ravn K., Wibrand F., Hansen F.J., Horn N., Rosenberg T., and Schwartz M. An mtDNA mutation, 14453G->A, in the NADH dehydrogenase subunit 6 associated with severe MELAS syndrome. Eur. J. Hum. Genet. 9 (2001) 805-809
55. Sakuta R., and Nonaka I. Vascular involvement in mitochondrial myopathy. Ann. Neurol. 25 (1989) 594-601
56. Santorelli F.M., Mak S.C., Vazquez-Acevedo M., Gonzlez-Halphen D., and DiMauro S. A novel mitochondrial DNA point mutation associated with mitochondrial encephalocardiomyopathy. Biochem. Biophys. Res. Commun. 216 (1995) 835-840
57. Santorelli F.M., Tanji K., Kulikova R., Shanske S., Vilarinho L., Hays A.P., and DiMauro S. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. Biochem. Biophys. Res. Commun. 238 (1997) 326-328
58. Santra S., Gilkerson R.W., Davidson M., and Schon E.A. Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells. Ann. Neurol. 56 (2004) 662-669
59. Sato W., Hayasaka K., Shoji Y., Takahashi T., Takada G., Saito M., Fukawa O., and Wachi E. A mitochondrial tRNA(Leu)(UUR) mutation at 3,256 associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Biochem. Mol. Biol. Int. 33 (1994) 1055-1061
60. Schröder R., Vielhaber S., Wiedemann F.R., Kornblum C., Papassotiropoulos A., Broich P., Zierz S., Elger C.E., Reichmann H., Seibel P., Klockgether T., and Kunz W.S. New insights in the metabolic consequences of large scale mtDNA deletions: a quantitative analysis of biochemical, morphological and genetic findings in human skeletal muscle. J. Neuropath. Exp. Neurol. 59 (2000) 353-360
61. 2+-induced epileptiform activity in rat hippocampal-entorhinal cortex slices. Neurobiol. Dis. 11 (2002) 96-105
62. Schuelke M., Bakker M., Stoltenburg G., Sperner J., and von Moers A. Epilepsia partialis continua associated with a homoplasmic mitochondrial tRNA(Ser(UCN)) mutation. Ann. Neurol. 44 (1998) 700-704
63. Shoffner J.M., Lott M.T., Lezza A.M., Seibel P., Ballinger S.W., and Wallace D.C. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 61 (1990) 931-937
64. Skulachev V.P. Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants. Q. Rev. Biophys. 29 (1996) 169-202
65. Shtilbans A., El-Schahawi M., Malkin E., Shanske S., Musumeci O., and DiMauro S. A novel mutation in the mitochondrial DNA transfer ribonucleic acid Asp gene in a child with myoclonic epilepsy and psychomotor regression. J. Child Neurol. 14 (1999) 610-613
66. Shtilbans A., Shanske S., Goodman S., Sue C.M., Bruno C., Johnson T.L., Lava N.S., Waheed N., and DiMauro S. G8363A mutation in the mitochondrial DNA transfer ribonucleic acidLys gene: another cause of Leigh syndrome. J. Child Neurol. 15 (2000) 759-761
67. Sullivan P.G., Geiger J.D., Mattson M.P., and Scheff S.W. Dietary supplement creatine protects against traumatic brain injury. Ann. Neurol. 48 (2000) 723-729
68. Suomalainen A., Majander A., Wallin M., et al. Autosomal dominant progressive external ophthalmoplegia with multiple deletions of mtDNA: clinical, biochemical, and molecular genetic features of the 10q-linked disease. Neurology 48 (1997) 1244-1253
69. Taniike M., Fukushima H., Yanagihara I., Tsukamoto H., Tanaka J., Fujimura H., Nagai T., Sano T., Yamaoka K., and Inui K. Mitochondrial tRNA(Ile) mutation in fatal cardiomyopathy. Biochem. Biophys. Res. Commun. 186 (1992) 47-53
70. Tang Y.G., and Zucker R.S. Mitochondrial involvement in post-tetanic potentiation of synaptic transmission. Neuron 18 (1997) 483-491
71. Taylor R.W., Chinnery P.F., Haldane F., Morris A.A., Bindoff L.A., Wilson J., and Turnbull D.M. MELAS associated with a mutation in the valine transfer RNA gene of mitochondrial DNA. Ann. Neurol. 40 (1996) 459-462
72. Taylor R.W., Singh-Kler R., Hayes C.M., Smith P.E., and Turnbull D.M. Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 gene. Ann. Neurol. 50 (2001) 104-107
73. Taylor R.W., Schaefer A.M., McDonnell M.T., Petty R.K., Thomas A.M., Blakely E.L., Hayes C.M., McFarland R., and Turnbull D.M. Catastrophic presentation of mitochondrial disease due to a mutation in the tRNA(His) gene. Neurology 62 (2004) 1420-1423
74. Tiranti V., Carrara F., Confalonieri P., Mora M., Maffei R.M., Lamantea E., and Zeviani M. A novel mutation (8342G->A) in the mitochondrial tRNA(Lys) gene associated with progressive external ophthalmoplegia and myoclonus. Neuromuscul. Disord. 9 (1999) 66-71
75. Turski W.A., Czuczwar S.J., Kleinrok Z., and Turski L. Cholinomimetics produce seizures and brain damage in rats. Experientia 39 (1983) 1408-1411
76. Urbanska E.M., Blaszczak P., Saran T., Kleinrok Z., and Turski W.A. Mitochondrial toxin 3-nitropropionic acid evokes seizures in mice. Eur. J. Pharmacol. 359 (1998) 55-58
77. Van Goethem G., Dermaut B., Lofgren A., et al. Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat. Genet. 28 (2001) 211-212
78. Varlamov D.A., Kudin A.P., Vielhaber S., Schröder R., Sassen R., Becker A., Kunz D., Haug D., Rebstock J., Heils A., Elger C.E., and Kunz W.S. Metabolic consequences of a novel missense mutation of the mtDNA CO I gene. Hum. Mol. Genet. 11 (2002) 1797-1805
79. Vielhaber S., von Oertzen J.H., Kudin A.P., Schoenfeld A., Menzel C., Biersack H.J., Kral T., Elger C.E., and Kunz W.S. Correlation of hippocampal glucose oxidation capacity and interictal FDG-PET in temporal lobe epilepsy. Epilepsia 44 (2003) 193-199
80. Vielhaber S., Kudin A.P., Kudina T.A., Stiller D., Scheich H., Schoenfeld A., Feistner H., Heinze H.J., Elger C.E., and Kunz W.S. Hippocampal N-acetyl aspartate levels do not mirror neuronal cell densities in creatine-supplemented epileptic rats. Eur. J. Neurosci. 18 (2003) 2292-22300
81. Vielhaber S., Niessen H.G., Debska-Vielhaber G., Kudin A.P., Wellmer J., Kaufmann J., Schönfeld M.A., Fendrich R., Willker W., Leibfritz D., Schramm J., Elger C.E., Heinze H.J., and Kunz W.S. Subfield-specific loss of hippocampal N-acetyl aspartate in temporal lobe epilepsy. Epilepsia 49 (2008) 40-50
82. Willmore L.J. Antiepileptic drugs and neuroprotection: current status and future roles. Epilepsy Behav. 7 Suppl 3 (2005) S25-S28
83. Winterthun S., Ferrari G., He L., et al. Autosomal recessive mitochondrial ataxic syndrome due to mitochondrial polymerase gamma mutations. Neurology 64 (2005) 1204-1208
84. Yamamoto H., and Tang H.W. Preventive effect of melatonin against cyanide-induced seizures and lipid peroxidation in mice. Neurosci. Lett. 207 (1996) 89-92
85. Zeviani M., Muntoni F., Savarese N., Serra G., Tiranti V., Carrara F., Mariotti C., and DiDonato S. A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA(Lys) gene. Eur. J. Hum. Genet. 1 (1993) 80-87
86. Zsurka G., Baron M., Stewart J.D., Kornblum C., Bös M., Sassen R., Taylor R.W., Elger C.E., Chinnery P.F., and Kunz W.S. Clonally expanded mitochondrial DNA mutations in epileptic individuals with mutated DNA polymerase gamma. J. Neuropathol. Exp. Neurol. 67 (2008) 857-866